Background/purpose: The isoniazid (INH) resistance of Mycobacterium tuberculosis is caused by mutations in the katG and inhA genes encoding for catalase-peroxidase and inhA, respectively. Sequences of the katG and inhA gene of 70 isolates were analyzed to identify the mutations and to compare the mutations with their related susceptibilities. Methods: Sequences of the katG and inhA genes and the resistance profiles were analyzed for the 70 M. tuberculosis isolates, collected from nine hospitals in Taiwan during the period from 1999 to 2011. Results: Fifteen alleles were identified in the katG gene and two alleles were identified in the inhA gene. Among the 15 alleles identified in the katG gene, 14 alleles were found in isolates resistant to isoniazid, while only three alleles were found in isolates susceptible to isoniazid. The mutations of the katG gene and their frequencies of 41 INH-resistant isolates were Arg463Leu (51%), Ser315Thr (29%), Ser315Asn (9.8%), and other loci (22%). The sensitivity and specificity of the Ser315Thr mutation for the detection of INH-resistant isolates were 29% and 100%, respectively. The frequency of inhA gene mutation was low (2.44%) in the 41 INHresistant isolates. Conclusion: The diverse alleles of the katG gene associated with INH resistance are present in the M. tuberculosis isolates in Taiwan. These data may be applied to develop new probes for various alleles associated with INH resistance in order to increase the sensitivity for the detection of genetically diverse M. tuberculosis isolates in different geographic areas. The diversity of mutations can also provide information for investigating the evolutional lineages of M. tuberculosis isolates.
Introduction
Mycobacterium tuberculosis (TB) infection has been an emerging global health issue. According to the World Health Organization (WHO) Global Tuberculosis Report 2012, 1 there were an estimated 8.7 million incident cases of TB in 2011. There were also 1.4 million deaths from TB (990,000 deaths among HIV-negative individuals and 430,000 among HIV-positive patients). There were an estimated 12 million prevalent cases of TB in 2011, equivalent to 170 cases per 100,000 population. Globally, 3.7% (2.1e5.2%) of new cases and 20% (13e26%) of previously treated cases are estimated to have MDR-TB (defined as resistance to at least isoniazid and rifampicin). In 2011, there were an estimated 630,000 cases of MDR-TB among the world's 12 million prevalent cases of TB. According to the Taiwan Tuberculosis Control Report 2012, 2 the annual incident cases of TB were 12,634 (54.5 cases per 100,000 population) in 2011, and the estimated rates of MDR-TB among new cases and previously treated cases were 1.0% and 6.7%, respectively. In a study conducted by a tertiary medical center in northern Taiwan in 2010, the resistance patterns of M. tuberculosis isolates from 326 patients were 12.0% for isoniazid, 2.8% for rifampicin, 1.5% for ethambutol, and 7.1% for streptomycin. 3 Isoniazid is a prodrug that is activated by the catalaseperoxidase enzyme encoded by the katG gene. Activated isoniazid disrupts the synthesis of essential mycolic acids by inhibiting inhA, the NADH-dependent enoyl-ACP reductase enzyme encoded by inhA gene. 4 Mutations of the katG gene and inhA gene lead to reduction or loss of the activity of catalase-peroxidase and structural change of the target of isoniazid, and both result in resistance to isoniazid. 5, 6 The GenoType MTBDRplus (Hain Lifescience GmbH, Nehren, Germany) is a test that uses PCR and DNA strip hybridization for the rapid detection of isoniazid and rifampicin resistance. The probes are designed to recognize mutations of the katG (S315T) and inhA (C15T A16G, T8C, and T8A) genes. A previous report in 2009 compared the performance of GenoType MTBDRplus test and DNA sequencing of the aforementioned loci in Taiwan. 7 The GenoType MTBDRplus test was less sensitive than DNA sequencing (81.8% vs. 93.4%) for the detection of isoniazid resistance because only limited codons were analyzed. The authors suggest that new alleles of INH-resistant genes are required to improve the sensitivity of GenoType MTBDRplus test. 7 Thus far, there has been no reports on the detailed single nucleotide mutations of the katG and inhA genes associated with resistance to isoniazid for M. tuberculosis isolates in Taiwan. Hence, we conducted this study to identify the detailed mutated sequences of the katG and inhA genes of 70 M. tuberculosis isolates collected in Taiwan during the period from 1999 to 2011. Sequences of their katG and inhA genes and resistance profiles of these isolates were analyzed and compared with the mutations of isoniazid-resistant strains from different geographic regions.
Materials and methods

Collection of M. tuberculosis isolates
Seventy M. tuberculosis isolates were collected for this study during the period from 1999 to 2011. Forty-six isolates were resistant to at least one of the four drugs, including isoniazid (INH), rifampicin (RMP), ethambutol (EMB), and streptomycin (SM). Forty-one of the 46 isolates were resistant to isoniazid. Among these 46 resistant isolates, 34 isolates were collected from Taichung Veterans General Hospital (TCVGH) and 12 isolates were collected from the other eight hospitals in northern Taiwan. Twenty-four isolates were susceptible to all the four drugs. Among these 24 susceptible isolates, 12 isolates were collected from TCVGH, and 12 isolates were collected from the other eight hospitals in northern Taiwan. The sources of specimens included sputum (62 isolates, 88.6%), cerebrospinal fluid (5, 7.1%), pleural effusion (2, 2.9%), and abscess (1, 1.4%).
Susceptibility test
The antimycobacterial susceptibility tests were performed according to the CLSI M24-A2 modified agar proportion method. 8 The procedure is performed by inoculating equal quantities of 100Â and 10,000Â dilutions of a standardized inoculum (0.5w1 McFarland) onto 7H10 agar medium (Bio Star, Taichung, Taiwan) with and without the test drug and then incubating them at 35 C, 10% CO 2 for 21 days. The number of colony-forming units growing on the drugcontaining medium compared with the number of those growing on the drug-free medium is then determined and expressed as a percentage. Resistance is defined as growth on drug-containing agar greater than 1% of the number of colonies that grow on the drug-free agar. The concentrations of antituberculosis drugs were as follows: isoniazid, 0.2 mg/mL; streptomycin, 2.0 mg/mL; rifampicin, 1.0 mg/ mL; and ethambutol, 5.0 mg/mL. Multidrug resistance was defined as isolates resistant to at least isoniazid and rifampicin. 8 
DNA sequencing
The DNA was extracted by 10 mg/mL of proteinase K and 5% Tween 20 in 200-mM Tris-HCl solution (pH Z 8.3) at 60 C overnight. The polymerase chain reaction (PCR) was performed in a GeneAmp PCR System 9600 (Perkin-Elmer, Norwalk, CT, USA) using the primer pairs listed in Table 1 . The PCR began with an initial 4-minute denaturation at 94 C, followed by 35 cycles of denaturation at 95 C for 1 minute, annealing at 55 C for 2 minutes, extension at 72 C for 2 minutes, and a final extension step at 72 C for 5 minutes. The sequence reactions were performed by adding fluorescent terminators (Perkin-Elmer Applied Biosystems, Foster City, CA, USA) and the primers used in the initial 
Susceptible to all four drugs (1) PCR. The sequences were determined with an ABI PRISM 310 and 3100 automated DNA sequencer (Perkin-Elmer Applied Biosystems, Foster City, CA). The sequences obtained from all 70 isolates were compared. Each unique mutated DNA fragment was defined as an allele.
Results
The mutations of the katG and inhA genes and their resistance profiles are listed in Table 2 and Table 3 , respectively. Fifteen alleles were indentified in the katG gene, and two alleles were identified in the inhA gene. Allele 1 represented the original sequence without mutation for both the katG and inhA genes. The other alleles demonstrated mutated sequences. Some of the alleles are listed in GenBank under accession numbers AY155347 to AY155354, AY178906, and AY155363.
Twenty-three isolates were assigned as allele 1 in the katG gene, including 14 isolates susceptible to isoniazid, and nine isolates resistant to isoniazid. Among the 15 alleles identified in the katG gene, 14 alleles were found in isolates resistant to isoniazid (alleles 1, 2, and 4e15), while only three alleles were found in isolates susceptible to isoniazid (alleles 1, 3, 4). The findings indicated that genetic polymorphisms in the katG gene could be associated with isoniazid resistance. The common mutations, Arg463Leu, Ser315Thr, and Ser315Asn, were identified in 8, 3, and 2 alleles, respectively. The mutations of the katG gene and their frequencies of the 41 INH-resistant isolates were Arg463Leu (51%), Ser315Thr (29%), Ser315Asn (9.8%), and other loci (22%). For the inhA gene, 69 isolates were assigned as allele 1, including 29 isolates susceptible to isoniazid and 40 isolates resistant to isoniazid. Only one isolate was assigned as allele 2 (Ile25Thr mutation), and it was resistant to all the four drugs.
The statistical data, including sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), of the katG gene mutations for detection of INH-resistance are listed in Table 4 . The sensitivity, specificity, PPV, and NPV of mutated codon 315 (Ser315Thr and Ser315Asn) were 39%, 100%, 100%, and 54%. Although the sensitivity for each of the other seven mutated codons (Tyr98Cys, Gln127Pro, Gly269Arg, Gln352Glu, Ala379Thr, Glu506stop, and insertion in the codon 518) was low (2.4%), the specificity and PPV for the detection of INH-resistance were 100%. Identify these eight mutated codons (315, 98, 127, 269, 352, 379, 506, and 518) in M. tuberculosis isolates may be helpful for the detection of INH-resistance because of the high specificity and PPV.
Discussion
This study demonstrated the relationship between the resistance profiles and the mutations of the katG and inhA genes of M. tuberculosis isolates in Taiwan over a 12-year period. There were significant genetic polymorphisms in the katG gene, especially in isolates that were resistant to isoniazid. The most common mutations among the a Ala202Ala was the silent mutation GCC202GCA. Thr203Thr was the silent mutation ACC203ACT. NPV Z negative predictive value; PPV Z positive predictive value.
41 isoniazid-resistant isolates were Arg463Leu (51%), Ser315Thr (29%), and Ser315Asn (9.8%). The Ser315Thr (S315T) mutation has been the most widely studied mutation of the katG gene worldwide and has been used in the GenoType MTBDRplus as a molecular target to detect isoniazid resistance. Enzymatic kinetic study demonstrated that the Ser315Thr mutation triggered the least catalase peroxidase activity among the 23 katG gene mutations tested, 9 which explained the high level of isoniazid resistance of the S315T mutation. 10 The frequency of Ser315Thr mutation in INH-resistant isolates varies in different geographic regions in the world, as shown in Table 5 . 7,11e21 In this study, the frequency of Ser315Thr mutation (29%) was comparable to the results of previous studies from the Mumbai (21.2%), 14 Korea (23.1%), 15 and Brazil (25%). 20 However, a higher frequency of Ser315Thr mutation in the katG gene was reported in other countries, such as Shanghai, China (62.8%), 11 Switzerland (65.6%), 19 Africa (71.9%), 18 and Russia (91.7%). 17 About 8.3% to 53% of mutations are located in the katG gene but not the Ser315Thr mutation.
The finding that the Ser315Thr mutation in the katG gene occurs less frequently in this study in Taiwan has a direct impact on the application of molecular techniques for rapid detection of MDR-TB. The probes used in the GenoType MTBDRplus are designed to recognize the mutations of the katG (S315T) and inhA (C15T A16G, T8C, and T8A) genes. By the GenoType MTBDRplus test, S315T mutation in the katG gene were found in 122 (50.4%) of 242 INH-resistant isolates collected in Taiwan. 7 Among the 41 INH-resistant isolates in this study, the katG mutations associated with resistance were S315T (29%) and other loci (48.8%). The sensitivity of GenoType MTBDRplus for detection of the mutated katG gene appears to be low for the isolates in this study. Therefore, it is reasonable to develop new probes of the katG genes for detection of the novel mutations which were selected under therapeutic pressure or evolved in different geographic areas.
The sensitivity and specificity of Arg463Leu mutation for the detection of INH resistance were only 51% and 48% in this study. In a previous study, the proportions of isolates from the Netherlands with Arg463Leu mutation were similar in INH-susceptible isolates and INH-resistant or INHintermediate isolates (32% and 29%, respectively). 22 Sitedirected mutagenesis experiments demonstrated that Arg463Leu mutation did not alter the activity of the catalase-peroxidase of M. tuberculosis. 23 These data suggested that the Arg463Leu mutation in the katG gene of M. tuberculosis did not confer resistance to INH. All of the isolates with the katG gene mutation were resistant to INH, except allele 3 and some of the isolates of allele 4. Allele 3 possessed the mutations of GCC202GCA and Arg463Leu. GCC202GCA is a silent mutation, and the Arg463Leu mutation does not confer to isoniazid resistance. Allele 4 contained Arg463Leu mutation alone. It was reasonable that allele 3 and some of the isolates of allele 4 were susceptible to INH.
Sreevatsan et al reported that the variants at katG codon 463 and gyrA codon 95 were present at high frequency. 24 These two mutation sites are apparently not related with antibiotic resistance and can be used as genetic markers to trace the history of evolutional divergence. 24 In the present study, nine isolates with the mutations of the katG gene located in codon 463 combined with other loci (315 and 463; 463 and 518; 203 and 463; 202, 315, and 463; 98, 379, and 463) were multidrug resistant. Further surveillance of the codon 463 and these mutation loci in M. tuberculosis isolates will be helpful for tracing the evolutional lineage of these resistant clones.
In contrast to the high frequencies of the katG gene mutations, the frequency (1 of 41 INH-resistant isolates) of the inhA gene mutation was low in this study. The only isolate with the inhA gene mutation also possessed Arg463Leu mutation in the katG gene. Among the 41 INHresistant isolates, 32 (78%) isolates had mutations in the katG gene, and nine isolates (22%) had neither inhA nor katG gene mutation. One of the possible mechanisms of the drug resistance of M. tuberculosis isolates with normal structural sequences of the inhA and katG gene may be mutation in the inhA regulatory region, 25 although it was not demonstrated in this study. However, the frequency of isoniazid resistance without mutations in the inhA regulatory region or the katG gene still ranged from 5.5w48.5% worldwide, as shown in Hazbón et al 29 indicated that most studies examined relatively small numbers of isolates or failed to include sufficient numbers of drug susceptible controls to demonstrate statistically significant associations between specific mutations and INH resistance. 6,17,23,26e35 The collection of drug-resistant isolates is often limited by the relatively low prevalence rate of drug-resistant M. tuberculosis isolates. This bias is also present in the research of frequency of rpoB gene mutations in M. tuberculosis isolates. 36 The limitation of this study is that small number of INH-resistant isolates and an insufficient amount of INH-susceptible isolates would result in bias in the proportion of resistant isolates among the collection. Therefore, we focused on the frequency of each point mutation in the resistant isolates rather than the proportion in all of the isolates. The drug-resistant isolates were collected from nine hospitals in Taiwan during a 12-year period to avoid sampling from a small region and in short period of time. The katG gene mutations have demonstrated the variations that can provide basic information for further investigations. Another limitation is that analysis of the regulatory region of the inhA gene was not performed because of the limited budget. Further investigation of the regulatory region of the inhA gene is promising for the detailed analysis of mutations related to INH-resistance.
In conclusion, the diverse alleles of the katG gene associated with INH-resistance are present in the M. tuberculosis isolates in Taiwan. These data may be applied to develop new probes for various alleles associated with INH-resistance, in order to increase the sensitivity for detection of genetically diverse M. tuberculosis isolates in different geographic areas. The diversity of mutations can also provide information for investigating the evolutional lineages of M. tuberculosis isolates.
